GCTx is based around TFome, a cellular programming platform built to “plug and play”—that is, to deliver off-the-shelf induced pluripotent stem cell (iPSC)-based medicines up to 100 times faster than conventional methods. The single-step process combines synthetic biology, gene editing, cell engineering and machine learning in efforts to boost potency, efficiency and quality, according to the company.
“This approach harnesses the transformative potential of transcription factor biology to guide iPSC cell fate into any differentiated cell type in a single, seamless step,” GCTx co-founder Church said in the company release. “By transcending the limitations of natural processes, it holds the promise to create cells that surpass the capabilities of those found in nature, generating a groundbreaking new class of SuperCell medicines to address diverse disease areas and reduce healthcare burdens.”
5 Likes
Seems like they’re saying they’ll take some stem cells - from me, or maybe those they created from Dr. Church’s skin - and manufacture therapeutic heart cells that will improve my heart, others that will do the same thing for my liver, kidneys, eyes - every organ, but separately for each organ and differntiated for each organ - not just treating diseased organs, but even improving already healthy organs.
4 Likes
1 Like